1. Adler, Arnon, Novelli, Valeria, Amin, Ahmad S, Wilde, Arthur A M, Gollob, Michael H. 2020. An International, Multicentered, Evidence-Based Reappraisal of Genes Reported to Cause Congenital Long QT Syndrome. In Circulation, 141, 418-428. doi:10.1161/CIRCULATIONAHA.119.043132. https://pubmed.ncbi.nlm.nih.gov/31983240/
2. Hamrick, Samantha K, Kim, C S John, Tester, David J, Gluscevic, Martina, Ackerman, Michael J. 2024. Single Construct Suppression and Replacement Gene Therapy for the Treatment of All CALM1-, CALM2-, and CALM3-Mediated Arrhythmia Disorders. In Circulation. Arrhythmia and electrophysiology, 17, e012036. doi:10.1161/CIRCEP.123.012036. https://pubmed.ncbi.nlm.nih.gov/39069900/
3. Wren, Lisa M, DeKeyser, Jean-Marc, Barefield, David Y, Wasserstrom, J Andrew, George, Alfred L. 2023. Sex and Gene Influence Arrhythmia Susceptibility in Murine Models of Calmodulinopathy. In Circulation. Arrhythmia and electrophysiology, 16, e010891. doi:10.1161/CIRCEP.122.010891. https://pubmed.ncbi.nlm.nih.gov/37589122/
4. Toutenhoofd, S L, Foletti, D, Wicki, R, Tolon, R, Strehler, E E. . Characterization of the human CALM2 calmodulin gene and comparison of the transcriptional activity of CALM1, CALM2 and CALM3. In Cell calcium, 23, 323-38. doi:. https://pubmed.ncbi.nlm.nih.gov/9681195/
5. Park, So-Young, Seo, Yu-Ri, Ko, Min Ji, Lee, Tae-Jin, Lee, Yun-Han. . Targeting CALM2 Inhibits Hepatocellular Carcinoma Growth and Metastasis by Suppressing E2F5-mediated Cell Cycle Progression. In Anticancer research, 41, 1315-1325. doi:10.21873/anticanres.14889. https://pubmed.ncbi.nlm.nih.gov/33788723/
6. Bortolin, Raul H, Nawar, Farina, Park, Chaehyoung, Bezzerides, Vassilios J, Pu, William T. 2024. Antisense Oligonucleotide Therapy for Calmodulinopathy. In Circulation, 150, 1199-1210. doi:10.1161/CIRCULATIONAHA.123.068111. https://pubmed.ncbi.nlm.nih.gov/39155863/
智鼠故事 
